Nuvaring 2.6 mg (Ethinyl Estradiol RING (SLOW-RELEASE)) 2.6 MG

NuvaRing 2.6 mg is a vaginal ring designed for hormonal birth control. This slow-release contraceptive contains ethinyl estradiol, offering convenience and effectiveness in preventing pregnancy. Ideal for those seeking a low-maintenance birth control option.

Strength

2.6 MG

Manufacturer / TM Owner

ORGANON CANADA INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

NuvaRing 2.6 mg is primarily used for birth control. This vaginal ring releases hormones to prevent ovulation and thicken cervical mucus, making it harder for sperm to reach the egg. It is a popular choice for women looking for a long-term, low-maintenance contraceptive solution. Many users also appreciate the convenience of a monthly insertion compared to daily pills.

Side Effects

Common effects of NuvaRing 2.6 mg may include mild vaginal irritation, headaches, and breast tenderness. Some users report changes in menstrual flow or spotting between periods. These effects are generally mild and temporary, but individual experiences can vary.

Precautions & Warnings

NuvaRing 2.6 mg should be handled with clean hands to avoid infection. It is important to follow the recommended usage guidelines and consult a healthcare provider before use. Women with a history of blood clots, heart disease, or certain cancers should discuss potential risks with their healthcare provider.

Avoid Interactions

NuvaRing 2.6 mg may interact with certain medications, including antibiotics and anticonvulsants. It is advisable to inform your healthcare provider about all medications you are taking. Alcohol and smoking can also affect the effectiveness and safety of hormonal contraceptives.

Frequently Asked Questions

NuvaRing 2.6 mg is primarily used for birth control. It releases hormones to prevent ovulation and thicken cervical mucus, making it harder for sperm to reach the egg.

NuvaRing 2.6 mg is typically replaced every three weeks, followed by a one-week break. Specific usage instructions should be discussed with a healthcare provider.

Common side effects may include mild vaginal irritation, headaches, and breast tenderness. Individual experiences can vary, and it is important to consult a healthcare provider if side effects are concerning.

NuvaRing 2.6 mg may not be suitable for everyone, especially those with a history of blood clots, heart disease, or certain cancers. Consult a healthcare provider to determine if it is appropriate for you.

NuvaRing 2.6 mg may interact with certain medications, including antibiotics and anticonvulsants. It is advisable to inform your healthcare provider about all medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.